Huashan Hospital

Running trials

• Recruiting

  Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease

  NCT07781644· Phase 2· Source

• Recruiting

  Effectiveness and Safety of Disease-Modifying Therapy for Alzheimer's Disease: A Multicenter Retrospective Study

  NCT07923812· Source

• Recruiting

  Sonrotoclax Plus Azacitidine in Patients With MDS-IB2

  NCT07885397· Phase 1/2· Source

• Recruiting

  Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults

  NCT07792681· Phase 2/3· Source

• Not yet recruiting

  Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults

  NCT07835152· Phase 3· Source

• Not yet recruiting

  Early Anticoagulation Therapy After Endovascular Treatment for Acute Ischemic Stroke With Atrial Fibrillation

  NCT07849777· Source

• Recruiting

  A Study of ATG-022 Compared With Investigator's Choice of Treatment in Claudin 18.2-Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

  NCT07795346· Phase 3· Source

• Not yet recruiting

  An Open-label, Dose-escalation Phase Ib Study of EA5 Injection in Adults With Anti-AChR Antibody-Positive Generalized Myasthenia Gravis

  NCT07818291· Phase 1· Source

• Recruiting

  Phase 1 Study of QX-4533 in Healthy Volunteers and Patients With Moderate-to-Severe Atopic Dermatitis

  NCT07800104· Phase 1· Source

• Recruiting

  A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis

  NCT07724366· Phase 3· Source

• Not yet recruiting

  A Cohort Study on the Integrated Management of Chronic Kidney Disease

  NCT07712341· Source

• Not yet recruiting

  PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke

  NCT07466251· Phase 4· Source

• Recruiting

  A Phase II Study of SHR-2173 Injection in Patients With Myasthenia Gravis

  NCT07622342· Phase 2· Source

• Recruiting

  ACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB)

  NCT07741461· Phase 1· Source

• Recruiting

  Development and Validation of Risk Prediction Models for Stroke and Cognitive Impairment in Moyamoya Disease and Moyamoya Syndrome

  NCT07894107· Source

• Recruiting

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· Phase 3· Source

• Recruiting

  A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.

  NCT07600788· Phase 1· Source

• Recruiting

  BRIGHT-Child TB: Short-Course Treatment for Non-Severe Pulmonary Tuberculosis in Children

  NCT07893444· Phase 2· Source

• Not yet recruiting

  Safety and Efficacy of Edaravone Dexborneol Sublingual Tablets for Blood-Brain Barrier Dysfunction in CADASIL

  NCT07692399· Phase 2· Source

• Recruiting

  A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSA

  NCT07604116· Phase 1· Source

• Recruiting

  A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and Pancreatic Cancer

  NCT07707531· Early phase 1· Source

• Recruiting

  A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD)

  NCT07513441· Phase 1· Source

• Recruiting

  A Multicenter, RAndomIzed, coNtrolled, umBrella Trial fOr Minimally Invasive Neurosurgery With AI-assisted Robotic guidanCe for Hemorrhagic Stroke

  NCT06459427· Source

• Recruiting

  A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis

  NCT07693738· Phase 1· Source

• Recruiting

  Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate Cancer

  NCT07310433· Phase 2· Source

• Recruiting

  Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease

  NCT07571161· Phase 3· Source

• Recruiting

  A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

  NCT07409181· Phase 2· Source

• Recruiting

  A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

  NCT07361302· Phase 3· Source

• Recruiting

  Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  NCT07353931· Phase 3· Source

• Recruiting

  A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma

  NCT07297212· Phase 2· Source

• Recruiting

  Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders

  NCT07381738· Phase 2· Source

• Recruiting

  Safety and Efficacy of Adipose-Derived Regenerative Cells (ADRCs) for Improving Hand Dysfunction in Systemic Sclerosis

  NCT07360808· Source

• Recruiting

  A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

  NCT07225946· Phase 3· Source

• Recruiting

  A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  NCT07218380· Phase 3· Source

• Recruiting

  Near-infrared Light Therapy Device for Mild-Moderate Alzheimer's Disease (NirsCure-03A)

  NCT07262645· Phase 3· Source

• Recruiting

  TITAN-HCC: Neoadjuvant and Adjuvant QL1706 With TACE in Resectable Hepatocellular Carcinoma Beyond Milan Criteria

  NCT07268131· Source

• Recruiting

  A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

  NCT07250802· Phase 3· Source

• Recruiting

  A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer

  NCT07255404· Phase 2· Source

• Recruiting

  Niaoduqing Granules in Older Adults With Impaired Kidney Function

  NCT07741292· Phase 4· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

  NCT07174310· Phase 3· Source

• Recruiting

  A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

  NCT07216027· Phase 2· Source

• Active, not recruiting

  Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) China Study

  NCT07216976· Source

• Recruiting

  This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

  NCT07290803· Source

• Recruiting

  Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma (CLEAR-2)

  NCT07331883· Phase 2· Source

• Recruiting

  CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection

  NCT06994975· Phase 3· Source

• Recruiting

  A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

  NCT07209761· Phase 3· Source

• Recruiting

  The Impact of Probiotic Intervention on the Gut Microbiota and Bowel Function

  NCT07369830· Source

• Recruiting

  Efficacy and Safety of QD202 in Participants With Acute Ischemic Stroke Undergoing Thrombolysis Excluding Endovascular Thrombectomy

  NCT07581210· Phase 2· Source

• Recruiting

  A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

  NCT07196722· Phase 2/3· Source

• Recruiting

  Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease

  NCT07166757· Phase 1/2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Stroke10 recruiting
• Myasthenia gravis8 recruiting
• Gastric and esophageal cancer7 recruiting
• Hepatitis B7 recruiting
• Alzheimer disease6 recruiting
• Atopic dermatitis (eczema)6 recruiting
• Chronic kidney disease5 recruiting
• Pancreatic cancer5 recruiting
• Parkinson disease5 recruiting
• Tuberculosis5 recruiting
• Childhood cancers3 recruiting
• Chronic lymphocytic leukaemia3 recruiting
• Colorectal cancer3 recruiting
• Migraine3 recruiting
• Psoriasis3 recruiting
• Fatty liver disease (MASLD/MASH)2 recruiting
• Glioblastoma2 recruiting
• Head and neck cancer2 recruiting
• Liver and biliary tract cancer2 recruiting
• Lupus (SLE)2 recruiting
• Prostate cancer2 recruiting
• Systemic sclerosis (scleroderma)2 recruiting
• Acute myeloid leukemia1 recruiting
• Atrial fibrillation1 recruiting
• Bladder cancer1 recruiting
• Crohn's disease1 recruiting
• Metastatic breast cancer1 recruiting
• Myelodysplastic syndromes1 recruiting
• Neuromyelitis optica (NMOSD)1 recruiting
• Obesity1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis Subjects

  NCT07357831· Phase 3· Source

• Terminated

  A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis

  NCT07100938· Phase 2· Source

• Completed

  HPP737 in Adult Patients With Plaque Psoriasis

  NCT07712731· Phase 3· Source

• Recruiting

  Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

  NCT06842199· Phase 3· Source

• Completed

  Efficacy and Safety of Roflumilast Cream in Subjects With Atopic Dermatitis

  NCT06631170· Phase 3· Source

• Completed

  A Trial of Rehabilitation Paired With VNS for Motor Function in Patients With Stroke (Repair Study)

  NCT06722677· Source

• Completed

  Comparative Study of CMAB015 and Secukinumab for Patients With Moderate to Severe Plaque Psoriasis

  NCT06398652· Phase 3· Source

• Completed

  A Phase I Clinical Trial of Single Subcutaneous Injection or Intravenous Infusion of SHR-1139 Injection in Healthy Chinese Subjects and Multiple Subcutaneous Injections in Patients With Moderate-to-severe Plaque Psoriasis

  NCT07051538· Phase 1· Source

• Completed

  A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis

  NCT06280716· Phase 3· Source

• Completed

  A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults

  NCT05989048· Phase 3· Source

• Terminated

  TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)

  NCT06106841· Phase 1/2· Source

• Completed

  BLAZE-Limiting Approach in NMOSD

  NCT06888622· Source

• Completed

  A Study to Extend Efficacy and Safety of SHR-1819 Injection in Adult Patients With Moderate to Severe Atopic Dermatitis

  NCT06012812· Phase 2· Source

• Completed

  Real World Study of Oral Upadacitinib Tablets to Assess Adverse Events and Change in Disease Activity in Adolescent and Adult Chinese Participants With Atopic Dermatitis

  NCT05959083· Source

• Completed

  A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight

  NCT05996848· Phase 3· Source

• Completed

  A Study of Dimethyl Fumarate (DMF) in Relapsing Forms of Multiple Sclerosis (RMS) Participants in China

  NCT05658484· Phase 4· Source

• Completed

  A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis

  NCT05507580· Phase 4· Source

• Completed

  A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.

  NCT05810038· Phase 3· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Moderate to Severe Plaque Psoriasis

  NCT06066125· Phase 3· Source

• Completed

  A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients With Lupus Nephritis (ZL-1103-013)

  NCT05810948· Phase 2· Source

• Completed

  rhPro-UK in Acute Ischaemic Stroke Within 4.5 Hours of Stroke Onset Trial 2(PROST-2)

  NCT05700591· Phase 3· Source

• Completed

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· Phase 3· Source

• Completed

  A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms

  NCT05559580· Phase 2· Source

• Completed

  A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

  NCT05601882· Phase 3· Source

• Completed

  A Phase I Study to Evaluate the Safety and Tolerability of JL15003 Injection in Patients With Recurrent Glioblastoma

  NCT07497373· Phase 1· Source

• Completed

  Functional Cure Rate of Peg-IFNα-2b Combined With TAF in HBeAg Negative CHB Patients

  NCT05490836· Source

• Completed

  Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration

  NCT05439629· Phase 3· Source

• Completed

  Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis

  NCT05332210· Phase 3· Source

• Completed

  The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)

  NCT05162586· Phase 2· Source

• Completed

  A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease

  NCT05029921· Phase 4· Source

• Terminated

  A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis

  NCT04963270· Phase 3· Source

• Completed

  A Study Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab in Chinese Patients With BRAF V600E Mutant Metastatic Colorectal Cancer.

  NCT05004350· Phase 2· Source

• Completed

  ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

  NCT05021835· Phase 3· Source

• Completed

  Long-term Safety and Efficacy of Adjunctive Brivaracetam in Chinese Patients With Uncontrolled Focal Epilepsy

  NCT07563634· Phase 3· Source

• Completed

  Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901

  NCT04805307· Phase 1· Source

• Completed

  A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus

  NCT04535544· Phase 2· Source

• Completed

  A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State

  NCT04451772· Phase 2· Source

• Completed

  A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis B

  NCT04225715· Phase 2· Source

• Completed

  Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study

  NCT04431895· Early phase 1· Source

• Completed

  A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)

  NCT04108208· Phase 4· Source

• Completed

  A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial Spondyloarthritis

  NCT04169373· Phase 3· Source

• Completed

  A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations

  NCT04083976· Phase 2· Source

• Completed

  Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

  NCT03422822· Phase 3· Source

• Completed

  Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

  NCT02003924· Phase 3· Source

• Completed

  Research and Validation of a Big Data-Driven Intelligent Decision-Making System for Hemodialysis

  NCT07466329· Source

• Completed

  Incremental Dialysis Decision Model Based on Expert-Guided Machine Learning

  NCT06775067· Source

Trial sites

• Department of Infectious Disease, Huashan Hospital1 trial
• Department of Neurology, Huashan Hospital, Fudan University1 trial
• Department of Neurosurgery, Huashan Hospital, Fudan University1 trial
• Huashan Hospital24 trials
• Huashan Hospital, affiliated to Fudan University, Shanghai,1 trial
• Huashan Hospital; Fudan U1 trial
• Huashan Hospital, Fudan University129 trials
• Huashan Hospital, Fudan University /ID# 2166461 trial
• Huashan Hospital, Fudan University /ID# 2229291 trial
• Huashan Hospital, Fudan University /ID# 2476801 trial
• Huashan Hospital, Fudan University /ID# 2500251 trial
• Huashan Hospital, Fudan University /ID# 2564561 trial
• Huashan Hospital, Fudan University, No. 12 Wulumuqi Middle Road, Jing'an District, Shanghai1 trial
• Huashan Hospital, Fudan University, Shanghai1 trial
• Huashan Hospital, Fudan University (Site 0103)1 trial
• Huashan Hospital, Fudan University (Site 0669)1 trial
• Huashan Hospital, Fudan University (Site 2821)1 trial
• Huashan Hospital, Fudan University (Site 3529)1 trial
• Huashan Hospital, Fudan University-Site Number: 15600121 trial
• Huashan Hospital, Shanghai Medical College, Fudan University1 trial
• Shanghai Huashan Hospital3 trials
• Fudan University - Huashan Hospital - Institute of Urology1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Stroke162 works · 13 trials
• Alzheimer disease114 works · 9 trials
• Parkinson disease60 works · 6 trials
• Glioblastoma38 works · 3 trials
• Psoriasis34 works · 13 trials
• Atopic dermatitis (eczema)30 works · 14 trials
• Myasthenia gravis26 works · 14 trials
• Osteoporosis21 works · 0 trials
• Hepatitis B18 works · 10 trials
• Systemic sclerosis (scleroderma)11 works · 3 trials
• Neuromyelitis optica (NMOSD)10 works · 2 trials
• Ankylosing spondylitis8 works · 1 trials
• Spinal muscular atrophy5 works · 1 trials
• IgA nephropathy5 works · 2 trials
• Sjögren's disease4 works · 0 trials
• CIDP (chronic inflammatory demyelinating polyneuropathy)3 works · 1 trials
• Pompe disease3 works · 0 trials